EUVIMEDEUVIMED entdecken
Crossref

Price competition in the chinese pharmaceutical market

Y Richard Wang

International Journal of Health Care Finance and Economics · 2006

DOI: 10.1007/s10754-006-5558-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Health Care Finance and Economics, 2006. Verfasst von Y Richard Wang. Beteiligte Einrichtung: Public Policy Department, AstraZeneca Pharmaceuticals 1800 Concord Pike, Wilmington, DE, 19850-5437, USA. y.richard.wang@astrazeneca.com. Hauptthemen laut MEDLINE: Developing Countries, Linear Models, Therapeutic Equivalency. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We study price competition between high-quality global products and low-quality local products in a developing country, i.e., China, Nearly all previous studies on pharmaceutical price competition focused on developed countries with bioequivalent generics. In China, local generic products are not bioequivalent and are deemed of lower quality, while global products in the same class are considered similar in quality and better substitutes. We hypothesize that local generic competition drives down local product price but not global product price. In addition, we hypothesize that therapeutic competition among similar global products lowers global product price. Our empirical results support both hypotheses. Number of local generic competitors has a significantly negative effect on local product price but no effect on global product price, while number of global therapeutic competitors has a significantly negative effect on global product price. Policy changes that encourage bioequivalent local products and accelerate global product approvals will enhance price competition in China.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Developing CountriesLinear ModelsTherapeutic EquivalencyChemistry, PharmaceuticalChinaDrug IndustryEconomic CompetitionHumansPrescription FeesQuality of Health Care

Autor:innen und Institutionen

  • Public Policy Department, AstraZeneca Pharmaceuticals 1800 Concord Pike, Wilmington, DE, 19850-5437, USA. y.richard.wang@astrazeneca.com

Zitieren

APA

Wang, Y. R. (2006). Price competition in the chinese pharmaceutical market. International Journal of Health Care Finance and Economics. https://doi.org/10.1007/s10754-006-5558-5

Vancouver

Wang YR. Price competition in the chinese pharmaceutical market. International Journal of Health Care Finance and Economics. 2006. doi:10.1007/s10754-006-5558-5

BibTeX
@article{Wang2006,
  author = {Wang, Y Richard},
  title = {Price competition in the chinese pharmaceutical market},
  journal = {International Journal of Health Care Finance and Economics},
  year = {2006},
  doi = {10.1007/s10754-006-5558-5}
}
Kostenlos starten →